The myth
Any source that names the ingredient supports the whole claim.
The fact
A drug listing, a professional policy, and a report of a medicine problem answer different questions; none can simply stand in for the others.
Basis: Read the source record
Legal and cost information is dated September 26, 2026.
FDA refers to the federal drug agency—the Food and Drug Administration.
Sources for this section
Match the record to the question
For product approval, look for the specific product and its form. In the September 2026 record, FDA explicitly says a National Drug Code entry does not establish approval or verification of the listed information. A genuine government link can therefore be used to imply something the record does not say.
Pharmacy-made medicines are called compounded drugs. Ask which medicine a claim concerns and which rule it relies on. The September 2026 record confirms that FDA does not review safety, quality, or effectiveness before these drugs are marketed. A finished product’s review cannot transfer to a different medicine.
For a professional policy, check who wrote it and what authority it has. The federation that brings state medical boards together publishes guidance; each state’s regulator has its own authority. Its remote-care model policy does not replace the binding rules of each state.
Read limits with the main statement
A source often carries the detail that keeps its headline from being overstated. Look for the named product, the people included, the type of record, and the date. Keep those details beside the claim instead of trimming them away to make the answer shorter.
FDA puts clear limits on its public event reports. They do not show cause, may contain information that has not been medically confirmed, and cannot show the rate at which an event occurs. Any account of those records needs to keep these limits.
FDA warning letters need a different limit. They describe issues alleged at a particular point, and later exchanges with the recipient may change the situation. A letter is not a final court finding, and the absence of a letter does not establish that a business has been cleared.
If a claim drops that limit, ask for it to be restored before comparing the claim with another source. A careful answer may be narrower than the advertisement. Narrower can still be useful when it addresses the actual decision.
Sources for this section
Keep the date and the original question
A rule, an offer, or a public list needs a date. Keep that date beside the conclusion it supports. If a source is older than a claim, ask whether the newer claim points to a newer record. An older record cannot settle what might have changed since.
An advisory vote would also be advice rather than a rule change. The September 2026 record says FDA must use a formal process to change the official ingredient list: propose a rule, invite public comments, and then decide on a final rule. A meeting alone does not change the list.
Write the unresolved question next to the source. If the source does not answer it, leave it open for the health professional rather than extend the source beyond its meaning. The practical reading habit is simple: ask the record to support the exact claim being made, with its limits still attached.
- What exact statement is this source being asked to support?
- Which limits belong with that statement?
- What does the record leave open?